- Home
- DKL vs TVTX Comparison
DKL vs TVTX Comparison
Compare DKL & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DKL
- TVTX
- Stock Information
- Founded
- DKL 2012
- TVTX 2008
- Country
- DKL United States
- TVTX United States
- Employees
- DKL N/A
- TVTX N/A
- Industry
- DKL Natural Gas Distribution
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- DKL Energy
- TVTX Health Care
- Exchange
- DKL Nasdaq
- TVTX Nasdaq
- Market Cap
- DKL 2.4B
- TVTX 2.5B
- IPO Year
- DKL N/A
- TVTX N/A
- Fundamental
- Price
- DKL $44.55
- TVTX $35.16
- Analyst Decision
- DKL Buy
- TVTX Strong Buy
- Analyst Count
- DKL 3
- TVTX 16
- Target Price
- DKL $47.00
- TVTX $35.20
- AVG Volume (30 Days)
- DKL 59.8K
- TVTX 2.0M
- Earning Date
- DKL 11-07-2025
- TVTX 10-30-2025
- Dividend Yield
- DKL 10.01%
- TVTX N/A
- EPS Growth
- DKL 1.28
- TVTX N/A
- EPS
- DKL 2.96
- TVTX N/A
- Revenue
- DKL $920,213,000.00
- TVTX $435,826,000.00
- Revenue This Year
- DKL $15.88
- TVTX $83.23
- Revenue Next Year
- DKL N/A
- TVTX $41.49
- P/E Ratio
- DKL $15.08
- TVTX N/A
- Revenue Growth
- DKL N/A
- TVTX 114.22
- 52 Week Low
- DKL $34.59
- TVTX $12.91
- 52 Week High
- DKL $48.00
- TVTX $35.34
- Technical
- Relative Strength Index (RSI)
- DKL 49.56
- TVTX 85.39
- Support Level
- DKL $43.20
- TVTX $26.79
- Resistance Level
- DKL $46.91
- TVTX $30.97
- Average True Range (ATR)
- DKL 0.93
- TVTX 1.22
- MACD
- DKL 0.05
- TVTX 0.38
- Stochastic Oscillator
- DKL 37.65
- TVTX 98.15
About DKL Delek Logistics Partners L.P. Common Units representing Limited Partner Interests
Delek Logistics Partners LP owns and operates logistics and marketing assets for crude oil and intermediate and refined products. The company's segment includes gathering and processing; wholesale marketing and terminalling; storage and transportation and investment in pipeline joint ventures. It generates maximum revenue from the wholesale marketing and terminalling segment, which provides marketing services for the refined products output of the Delek Holdings' refineries, engages in wholesale activity at its terminals and terminals owned by third parties, whereby it purchases light product for sale and exchange to third parties, and provides terminalling services at its refined products terminals to independent third parties and Delek Holdings.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.